Takeda Pharmaceutical annual operating margin
2017
2018
2019
2020
2021
2022
2023
2024
2025
Takeda Pharmaceutical's operating margin was 7.48% for fiscal 2025.
View full Takeda Pharmaceutical company overview| Fiscal year | Period ended | Operating margin | Change (percentage points) |
|---|---|---|---|
| 2025 | 2025-03-31 | 7.48% | +2.46 pp |
| 2024 | 2024-03-31 | 5.02% | −7.16 pp |
| 2023 | 2023-03-31 | 12.18% | −0.73 pp |
| 2022 | 2022-03-31 | 12.91% | −3.01 pp |
| 2021 | 2021-03-31 | 15.93% | +12.87 pp |
| 2020 | 2020-03-31 | 3.05% | −8.28 pp |
| 2019 | 2019-03-31 | 11.33% | −2.32 pp |
| 2018 | 2018-03-31 | 13.66% | +4.66 pp |
| 2017 | 2017-03-31 | 9.00% | — |
| Fiscal quarter | Period ended | Operating margin | Change (percentage points) |
|---|
Over the last five reported fiscal years, Takeda Pharmaceutical's operating margin increased from 3.05% to 7.48%, a change of +4.43 percentage points.
Operating margin measures the percentage of revenue left after operating costs and expenses. It shows how much operating profit a company generates from each dollar of revenue.
TickerStat calculates operating margin as SEC-reported operating income divided by SEC-reported revenue for the same fiscal period. Changes are shown in percentage points. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Takeda Pharmaceutical filings at SEC.gov ↗